Phase
Condition
Pain
Treatment
The triamcinolone acetonide plus ropivacaine group
The ropivacaine group
Clinical Study ID
Ages 2-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
-(1) Age 2 to 12 years. (2) American Society of Anesthesiologists (ASA) physical status I or II. (3)Participates with an anticipated fully recovery within 2 hours postoperatively.
(4)Informed consent by parent(s) and/or legal guardian.
Exclusion
Exclusion Criteria:
- (1) Allergy to local anesthetics. (2) Pediatric patients aged>12 or <2 years. (3)Under medication with analgesic drugs. (4) Psychiatric disorders. (5) Uncontrolledepilepsy. (6) Chronic headache. (7) Peri-incisional infection. (8) Coagulopathy orbleeding disorder. (9) Patients who are expected to remain intubated and mechanicalventilation after surgery.
(10) Emergency craniotomies. (11) Patients with cardiac insufficiency or severe kidney or liver diseases. (12) Patients whose authorized surrogates are unwilling to participate in the study
Study Design
Connect with a study center
Beijing Tiantan Hospital
Beijing, Beijing 100070
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.